Cargando…
Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania
Previous work from our group showed that tamoxifen, an oral drug that has been in use for the treatment of breast cancer for over 40 years, is active both in vitro and in vivo against several species of Leishmania, the etiological agent of leishmaniasis. Using a combination of metabolic labeling wit...
Autores principales: | Trinconi, Cristiana T., Miguel, Danilo C., Silber, Ariel M., Brown, Christopher, Mina, John G.M., Denny, Paul W., Heise, Norton, Uliana, Silvia R.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216108/ https://www.ncbi.nlm.nih.gov/pubmed/30399513 http://dx.doi.org/10.1016/j.ijpddr.2018.10.007 |
Ejemplares similares
-
Leishmania is not prone to develop resistance to tamoxifen
por: Coelho, Adriano C., et al.
Publicado: (2015) -
Tamoxifen Is Effective in the Treatment of Leishmania amazonensis Infections in Mice
por: Miguel, Danilo C., et al.
Publicado: (2008) -
In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis
por: Coelho, Adriano C., et al.
Publicado: (2014) -
In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis: Follow-Up
por: Coelho, Adriano C., et al.
Publicado: (2016) -
Proper regulation of inositolphosphorylceramide levels is required for acquirement of low pH resistance in budding yeast
por: Otsu, Mikiko, et al.
Publicado: (2020)